Just Healthcare

Just Healthcare

Share this post

Just Healthcare
Just Healthcare
Low-Dose Aspirin Shows Promise for Preventing Colorectal Cancer Recurrence
Copy link
Facebook
Email
Notes
More

Low-Dose Aspirin Shows Promise for Preventing Colorectal Cancer Recurrence

A targeted approach using aspirin reduces recurrence risk in patients with PI3K pathway mutations

Naveen Sankar S's avatar
Naveen Sankar S
Jan 30, 2025
∙ Paid

Share this post

Just Healthcare
Just Healthcare
Low-Dose Aspirin Shows Promise for Preventing Colorectal Cancer Recurrence
Copy link
Facebook
Email
Notes
More
Share
A modern, professional medical illustration depicting the positive impact of low-dose aspirin on colorectal cancer recurrence reduction. The image features a stylized DNA strand representing genetic research, alongside a simplified human colon graphic. A subtle overlay of a pill icon symbolizes aspirin's role in treatment. The background conveys an innovative and hopeful tone with soft, clean gradients, ensuring an approachable and visually engaging style.

Key Takeaway

A phase 3 clinical trial revealed that daily low-dose aspirin significantly reduces colorectal cancer (CRC) recurrence in patients with specific genetic mutations in the PI3K signaling pathway.

Understanding the Study

The ALASCCA trial, presented at the 2025 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium, inves…

Keep reading with a 7-day free trial

Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Just Healthcare
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More